JP2002161074A5 - - Google Patents

Download PDF

Info

Publication number
JP2002161074A5
JP2002161074A5 JP2001255372A JP2001255372A JP2002161074A5 JP 2002161074 A5 JP2002161074 A5 JP 2002161074A5 JP 2001255372 A JP2001255372 A JP 2001255372A JP 2001255372 A JP2001255372 A JP 2001255372A JP 2002161074 A5 JP2002161074 A5 JP 2002161074A5
Authority
JP
Japan
Prior art keywords
neuraminidase
compound
label
sample
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001255372A
Other languages
English (en)
Japanese (ja)
Other versions
JP4234917B2 (ja
JP2002161074A (ja
Filing date
Publication date
Priority claimed from US08/476,946 external-priority patent/US5866601A/en
Application filed filed Critical
Publication of JP2002161074A publication Critical patent/JP2002161074A/ja
Publication of JP2002161074A5 publication Critical patent/JP2002161074A5/ja
Application granted granted Critical
Publication of JP4234917B2 publication Critical patent/JP4234917B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001255372A 1995-02-27 2001-08-24 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター Expired - Lifetime JP4234917B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US39524595A 1995-02-27 1995-02-27
US08/395,245 1995-02-27
US08/476,946 1995-06-06
US08/476,946 US5866601A (en) 1995-02-27 1995-06-06 Carbocyclic compounds
US58056795A 1995-12-29 1995-12-29
US08/580,567 1995-12-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP52644296A Division JP3300365B2 (ja) 1995-02-27 1996-02-26 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2005207906A Division JP2006036770A (ja) 1995-02-27 2005-07-15 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
JP2008082197A Division JP2008273948A (ja) 1995-02-27 2008-03-26 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Publications (3)

Publication Number Publication Date
JP2002161074A JP2002161074A (ja) 2002-06-04
JP2002161074A5 true JP2002161074A5 (https=) 2005-10-27
JP4234917B2 JP4234917B2 (ja) 2009-03-04

Family

ID=27410155

Family Applications (3)

Application Number Title Priority Date Filing Date
JP52644296A Expired - Lifetime JP3300365B2 (ja) 1995-02-27 1996-02-26 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
JP2001255372A Expired - Lifetime JP4234917B2 (ja) 1995-02-27 2001-08-24 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
JP2005207906A Withdrawn JP2006036770A (ja) 1995-02-27 2005-07-15 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP52644296A Expired - Lifetime JP3300365B2 (ja) 1995-02-27 1996-02-26 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005207906A Withdrawn JP2006036770A (ja) 1995-02-27 2005-07-15 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Country Status (26)

Country Link
US (3) US5952375A (https=)
EP (1) EP0759917B1 (https=)
JP (3) JP3300365B2 (https=)
KR (1) KR100447096B1 (https=)
CN (2) CN1185223C (https=)
AT (2) ATE191711T1 (https=)
AU (1) AU720933B2 (https=)
BR (2) BR9607098B8 (https=)
CZ (1) CZ297945B6 (https=)
DE (4) DE69607704T2 (https=)
DK (1) DK0759917T3 (https=)
ES (2) ES2249863T3 (https=)
GR (1) GR3033914T3 (https=)
HU (1) HU228450B1 (https=)
LU (1) LU90991I2 (https=)
MX (1) MX9706496A (https=)
NL (1) NL300105I2 (https=)
NO (1) NO318455B1 (https=)
NZ (1) NZ306625A (https=)
PL (1) PL194173B1 (https=)
PT (1) PT759917E (https=)
RU (1) RU2181357C2 (https=)
SG (1) SG45864A1 (https=)
SI (1) SI9620042A (https=)
UA (1) UA56128C2 (https=)
WO (1) WO1996026933A1 (https=)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9607098B8 (pt) 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
DE69711395T2 (de) * 1996-08-23 2002-11-07 Gilead Sciences, Inc. Verfahren zur herstellung von cyclohexen-carboxylatderivate
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
CA2268756A1 (en) * 1996-10-21 1998-04-30 Gilead Sciences, Inc. Piperidine compounds
NZ335368A (en) * 1996-11-14 2001-08-31 Biota Scient Management Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase
AU8673598A (en) * 1997-08-01 1999-02-22 University Of Florida Neuraminidase inhibitors
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
NZ502988A (en) * 1997-09-17 2002-08-28 Gilead Sciences Inc 5-Acetamido-4-amino-2-propionyloxy-6-isopropoxy-1-cyclohexene useful for treating influenza
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
CA2315262C (en) * 1997-12-17 2009-11-10 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
EP1315698A1 (en) * 1998-04-23 2003-06-04 Abbott Laboratories Pyrrolidines as inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
DE69900483T2 (de) * 1998-05-13 2002-06-27 F. Hoffmann-La Roche Ag, Basel Verfahren zur Herstellung von Shikiminsäure und deren Derivate
WO2000029385A1 (en) * 1998-11-13 2000-05-25 Gilead Sciences, Inc. 1,4,5,6-tetrahydro-pyridazine derivatives, their preparation and their use as neuraminidase inhibitors
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
ES2198244T3 (es) * 1999-06-11 2004-02-01 F. Hoffmann-La Roche Ag Procedimiento para la preparacion de inhibidor ro-64-0796 de la neuraminidasa.
DE19930177B4 (de) 1999-06-30 2007-02-08 Nikolai Vladimirovich Bovin Intermolekular assoziierende Verbindungen und deren Verwendung
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
BR0010525A (pt) * 1999-10-19 2002-11-26 Abbott Lab cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase
US6627396B1 (en) * 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
JP2001131144A (ja) 1999-11-02 2001-05-15 Sagami Chem Res Center ７−アザビシクロ［４．１．０］ヘプト−３−エン−３−カルボン酸エステル類の製造方法
US6462226B1 (en) 1999-12-03 2002-10-08 Hoffmann-La Roche Inc. Process for the preparation of 4,5-diamino shikimic acid derivatives
EP1486499A1 (en) 1999-12-27 2004-12-15 Sagami Chemical Research Center Endo-2,3-epoxy-7-oxabicylco[2.2.1]heptane-endo-5-carboxylic acid derivative
US8642051B2 (en) * 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AU2001281846B2 (en) 2000-06-27 2006-04-27 Cheplapharm Arzneimittel Gmbh Method for preparing a composition
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US6964784B2 (en) 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
RU2220739C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Интраназальное средство
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
DE602004031115D1 (de) 2003-06-16 2011-03-03 Acad Of Science Czech Republic Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
WO2007053792A2 (en) * 2005-11-05 2007-05-10 Amplyx Pharmaceuticals, Inc. Improving the pharmacokinetics of protease inhibitors and other drugs
US7687658B2 (en) 2005-11-25 2010-03-30 Hetero Drugs Limited Process for oseltamivir phosphate
KR100819759B1 (ko) 2005-12-01 2008-04-07 (주)파인켐 아자이드 화합물의 폭발성을 제거한 공정을 이용한 1,2-다이아미노 화합물 또는 이의 부가염 제조 방법
EP2178819A2 (en) 2005-12-28 2010-04-28 F.Hoffmann-La Roche Ag Epoxide intermediate in the tamiflu synthesis
AU2007218733B2 (en) 2006-02-20 2012-11-15 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080306098A1 (en) * 2006-11-06 2008-12-11 Mutz Mitchell W Pharmacokinetics of protease inhibitors and other drugs
US8227425B2 (en) 2007-01-23 2012-07-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US8435769B2 (en) 2007-04-13 2013-05-07 Monsanto Technology Llc Use of glyphosate to produce shikimic acid in microorganisms
US20090054334A1 (en) * 2007-05-23 2009-02-26 Mutz Mitchell W Combinatorial improvement of bifunctional drug properties
JP5509080B2 (ja) * 2007-08-31 2014-06-04 アカデミア シニカ 抗インフルエンザ活性を有するオセルタミビル含有ホスホネートコンジナーの合成
EP2201123B1 (en) 2007-10-16 2012-01-18 Monsanto Technology, LLC Processes for recovering shikimic acid
WO2009055042A1 (en) * 2007-10-24 2009-04-30 Amplyx Pharmaceuticals, Inc. Enhancing the efficacy of anti-infective therapeutics
US8304553B2 (en) * 2007-12-19 2012-11-06 Nanyang Technological University Method of forming oseltamivir and derivatives thereof
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
US20120058937A9 (en) 2008-04-15 2012-03-08 Tsrl, Inc. Prodrugs of Neuraminidase Inhibitors
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CN101486664B (zh) * 2008-12-31 2013-09-04 北京大学深圳研究生院 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物
EA201101564A1 (ru) 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
WO2011021223A2 (en) * 2009-08-19 2011-02-24 Msn Laboratories Limited Novel salts of ethyl (3r, 4s, 5r)-4,5-imino-3-(l-ethylpropoxy)-1- cvclohexene-1-carboxylate and its use
JP5837502B2 (ja) * 2009-11-11 2015-12-24 スリーエム イノベイティブ プロパティズ カンパニー ポリマー組成物並びにその製造方法及び物品
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
EA201300142A1 (ru) 2010-07-16 2013-08-30 Гриндекс, Джоинт Сток Кампани Производные 1,4-дигидропиридина, обладающие противовирусной эффективностью
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
EP2578218A1 (en) 2011-10-06 2013-04-10 Grindeks, A Joint Stock Company Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives
DE102011117128A1 (de) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2489422C1 (ru) * 2012-05-12 2013-08-10 Александр Васильевич Иващенко Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси)циклогексен-1-карбоновые кислоты, их эфиры и способ применения
RU2521593C1 (ru) * 2013-02-27 2014-06-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Моно и дифторзамещенные этил (3r,4r,5s)-5-азидо-4-ацетиламино-3-(1-этилпропокси)-циклогексен-1-карбоксилаты, способ получения и применения
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
CN103819357B (zh) * 2014-01-28 2016-03-16 浙江大学 (-)-有效霉醇叠氮四乙酸酯的制备方法
KR20160124764A (ko) 2014-02-14 2016-10-28 도아 에이요 가부시키가이샤 고리형 탄화수소 화합물
US20170100385A1 (en) 2014-05-12 2017-04-13 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions comprising danirixin for treating infectious diseases
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
GB2532178A (en) * 2014-06-09 2016-05-18 Redx Pharma Plc Antiviral compounds
DK3236972T3 (en) 2014-12-26 2021-10-04 Univ Emory Antivirale N4-hydroxycytidin-derivativer
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US10676428B2 (en) 2015-12-17 2020-06-09 Ramot At Tel-Aviv University Ltd. Antiviral agents for amantadine-resistant influenza A
KR102339817B1 (ko) 2016-06-30 2021-12-16 한미약품 주식회사 오셀타미비어 함유 경구용 고형제제 및 그 제조방법
RU2727962C1 (ru) * 2016-08-10 2020-07-28 Сионоги Энд Ко., Лтд. Фармацевтические композиции, содержащие замещенные полициклические пиридоновые производные и их пролекарство
JP6804790B1 (ja) 2017-12-07 2020-12-23 エモリー ユニバーシティー Ｎ４−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途
KR20200106607A (ko) 2019-03-05 2020-09-15 주식회사 코아팜바이오 오셀타미비르 함유 의약 조성물
WO2025221915A1 (en) * 2024-04-16 2025-10-23 University Of Utah Research Foundation Synthesis of gadusol and related compounds

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968788A (en) * 1986-04-04 1990-11-06 Board Of Regents, The University Of Texas System Biologically reversible phosphate and phosphonate protective gruops
US5206400A (en) * 1986-07-07 1993-04-27 Ohio State University Diastereomeric mono- and di-substituted diamino cyclohexane compounds and the method of preparation thereof
DE68926743T2 (de) * 1988-01-12 1997-01-09 Univ Texas Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate
US5175273A (en) * 1988-07-01 1992-12-29 Genentech, Inc. Nucleic acid intercalating agents
US5270340A (en) * 1988-12-27 1993-12-14 Bayer Aktiengesellschaft Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents
GB2238049A (en) * 1989-11-22 1991-05-22 Ki Nii Epidemiologii I Infekts Method for preparing inhibitor for influenza virus neuraminidase
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
DE4033415A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Antimikrobielle mittel sowie substituierte 2-cyclohexan-1-yl-amin-derivate und deren herstellung
DE4131311A1 (de) * 1991-09-20 1993-04-01 Basf Ag Dihydropyranderivate und diese enthaltende pflanzenschutzmittel
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5292938A (en) * 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
US5633360A (en) 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
US5639786A (en) * 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
US5514798A (en) * 1993-06-02 1996-05-07 Gilead Sciences, Inc. Method and cyclic carbonates for nucleotide analogues
US5819730A (en) * 1993-06-09 1998-10-13 Glaxo Wellcome Australia Ltd. Device for administering pharmaceutical substances
GB9311873D0 (en) * 1993-06-09 1993-07-28 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
WO1996014314A2 (en) 1994-11-04 1996-05-17 Gilead Sciences, Inc. Thiepane compounds inhibiting and detecting hiv protease
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
BR9607098B8 (pt) * 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
US5602277A (en) 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
GB9510141D0 (en) 1995-05-19 1995-07-12 Biota Scient Management Chemical compounds
GB9525389D0 (en) 1995-12-12 1996-02-14 Biota Scient Management Ltd Chemical compounds
HUP9801766A3 (en) * 1995-05-19 2000-09-28 Biota Scient Managemant Pty Lt 6-carboxamido dihydropyran derivatives, process for producing them and medicaments containing the same
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
DE69711395T2 (de) 1996-08-23 2002-11-07 Gilead Sciences, Inc. Verfahren zur herstellung von cyclohexen-carboxylatderivate
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US5948816A (en) * 1996-09-10 1999-09-07 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
US5886213A (en) 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds

Similar Documents

Publication Publication Date Title
JP2002161074A5 (https=)
JP2019218375A5 (https=)
JP2004503248A5 (https=)
JP2009511595A5 (https=)
JP2011528713A5 (https=)
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
JP2002540208A5 (https=)
JP2002501049A5 (https=)
IL173712A0 (en) Transdermal pharmaceutical preparation containing active substance combinations, for treating parkinson's disease
KR900013984A (ko) 항-바이러스 치료를 위한 세포간 점착 분자 icam-1의 작용성 유도체의 용도
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
RU95113474A (ru) Применение 2-амино-6-н-пропиламино-4,5,6,7-тетрагидробензотиазола, его энантиомеров и фармакологически переносимых кислотноаддитивных солей в качестве антидепрессанта и фармацевтическая композиция с антидепрессивной активностью на их основе
EP1116711A3 (de) 2-Aminoalkyl-1,4-diaminobenzol-Derivate und diese Verbindungen enthaltende Färbemittel
CA2399368A1 (en) Fluorescent detection method and reagent
BR0201524A (pt) Tratamento de combinação para ansiedade e depressão
JP2004502684A5 (https=)
JP2011508779A5 (https=)
JP2003507721A5 (https=)
EP1153998A4 (en) COATING COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
JP2005513036A5 (https=)
FR2967576B1 (fr) Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
BR112012021532B1 (pt) Composição para tratamento de unhas com fungo
JP2004510749A5 (https=)
EP0948967A3 (en) Treatment of viral disease in swine
JP2000319116A5 (https=)